Accendra Health Inc (ACH) stock
ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.15+0.00 (+0.55%)
Close on Nov 12, 2026Market cap $11.23MP/E –Yield –
Accendra Health gross margin
Gross margin is gross profit as a percentage of revenue.
Accendra Health's gross margin for the twelve months ending Sep 30, 2026 was 44.1%. For fiscal 2025 it was 46.7%, against 82.8% the year before. The highest annual figure on record is 83.3% in fiscal 2023.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 46.7% | −36.1 |
| FY2024 | Dec 31, 2024 | 82.8% | −0.5 |
| FY2023 | Dec 31, 2023 | 83.3% | +64.9 |
| FY2022 | Dec 31, 2022 | 18.3% | +2.9 |
| FY2021 | Dec 31, 2021 | 15.5% | +0.4 |
| FY2020 | Dec 31, 2020 | 15.1% | +2.9 |
| FY2019 | Dec 31, 2019 | 12.3% | +0.9 |
| FY2018 | Dec 31, 2018 | 11.4% | −1.2 |
| FY2017 | Dec 31, 2017 | 12.6% | +0.4 |
| FY2016 | Dec 31, 2016 | 12.2% | −0.2 |
| FY2015 | Dec 31, 2015 | 12.4% | +0.0 |
| FY2014 | Dec 31, 2014 | 12.4% | +0.1 |
| FY2013 | Dec 31, 2013 | 12.3% | +1.9 |
| FY2012 | Dec 31, 2012 | 10.4% | +0.5 |
| FY2011 | Dec 31, 2011 | 9.9% | −0.0 |
| FY2010 | Dec 31, 2010 | 9.9% | −0.2 |
| FY2009 | Dec 31, 2009 | 10.1% | −0.1 |
| FY2008 | Dec 31, 2008 | 10.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 43.4% | −2.8 |
| Q2 FY2026 | Jun 30, 2026 | 43.0% | −4.6 |
| Q1 FY2026 | Mar 31, 2026 | 44.3% | −33.8 |
| Q4 FY2025 | Dec 31, 2025 | 45.6% | −37.8 |
| Q3 FY2025 | Sep 30, 2025 | 46.2% | −35.3 |
| Q2 FY2025 | Jun 30, 2025 | 47.6% | −34.8 |
| Q1 FY2025 | Mar 31, 2025 | 78.1% | +57.6 |
| Q4 FY2024 | Dec 31, 2024 | 83.4% | +62.0 |
| Q3 FY2024 | Sep 30, 2024 | 81.5% | +60.7 |
| Q2 FY2024 | Jun 30, 2024 | 82.4% | +62.1 |
| Q1 FY2024 | Mar 31, 2024 | 20.5% | +0.8 |
| Q4 FY2023 | Dec 31, 2023 | 21.5% | +5.5 |
| Q3 FY2023 | Sep 30, 2023 | 20.8% | +0.2 |
| Q2 FY2023 | Jun 30, 2023 | 20.3% | −1.0 |
| Q1 FY2023 | Mar 31, 2023 | 19.7% | +4.2 |
| Q4 FY2022 | Dec 31, 2022 | 16.0% | +2.1 |
| Q3 FY2022 | Sep 30, 2022 | 20.6% | +7.4 |
| Q2 FY2022 | Jun 30, 2022 | 21.3% | +5.2 |
| Q1 FY2022 | Mar 31, 2022 | 15.5% | −3.5 |
| Q4 FY2021 | Dec 31, 2021 | 13.8% | −3.0 |
| Q3 FY2021 | Sep 30, 2021 | 13.1% | −2.6 |
| Q2 FY2021 | Jun 30, 2021 | 16.1% | +1.2 |
| Q1 FY2021 | Mar 31, 2021 | 19.0% | +6.4 |
| Q4 FY2020 | Dec 31, 2020 | 16.9% | +3.9 |
| Q3 FY2020 | Sep 30, 2020 | 15.7% | +3.5 |
| Q2 FY2020 | Jun 30, 2020 | 14.9% | +2.8 |
| Q1 FY2020 | Mar 31, 2020 | 12.7% | +0.9 |
| Q4 FY2019 | Dec 31, 2019 | 13.0% | +9.8 |
| Q3 FY2019 | Sep 30, 2019 | 12.2% | −2.1 |
| Q2 FY2019 | Jun 30, 2019 | 12.1% | −1.2 |
| Q1 FY2019 | Mar 31, 2019 | 11.8% | −1.9 |
| Q4 FY2018 | Dec 31, 2018 | 3.2% | −10.0 |
| Q3 FY2018 | Sep 30, 2018 | 14.3% | +1.4 |
| Q2 FY2018 | Jun 30, 2018 | 13.2% | +1.1 |
| Q1 FY2018 | Mar 31, 2018 | 13.7% | +1.6 |
| Q4 FY2017 | Dec 31, 2017 | 13.2% | +0.7 |
| Q3 FY2017 | Sep 30, 2017 | 12.9% | – |
| Q2 FY2017 | Jun 30, 2017 | 12.1% | – |
| Q1 FY2017 | Mar 31, 2017 | 12.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 12.5% | – |
See a number that looks wrong?